|
17/12/2020 |
SOBERANA 02A |
FINLAY |
Registered outdated |
|
03/03/2021 |
SOBERANA 02-FaseIII |
FINLAY |
Registered |
|
27/10/2020 |
SOBERANA 02 |
FINLAY |
Registered |
|
05/01/2021 |
SOBERANA 01B |
FINLAY |
Registered |
|
17/10/2020 |
SOBERANA 01A |
FINLAY |
Registered |
|
13/08/2020 |
SOBERANA 01 |
FINLAY |
Registered outdated |
|
19/03/2021 |
SOBERANA - INTERVENTION |
FINLAY |
Registered |
|
30/08/2022 |
Sinopharm-SOBERANA COVID-Cienfuegos |
FINLAY |
Registered |
|
09/07/2020 |
Second Line-Acute Asthma |
SAHUAPA |
Registered outdated |
|
25/09/2015 |
Seawater-Rhinitis-Children-Phase III |
UDEA |
Registered |
|
2013-01-30 |
Safety with interferon in skin carcinomas (SCIENCE study) |
CIGB |
Registered |
|
21/07/2023 |
Safety of Orally Administered Neutral pH Super Oxidation Electrolyzed Solution |
SSA |
Registered |
|
2009-07-03 |
Safety evaluation of Recombinant Human Erythropoietin ior EPOCIM in the treatment of patient with cerebral infarction acute. Study Stage I. |
CIMAB |
Registered outdated |
|
07/08/2023 |
Safety evaluation of Bacillus coagulans AO1167 for its use as a probiotic in humans |
HHA |
Registered |
|
07/08/2023 |
Safety evaluation of Bacillus clausii AO1125 for its use as a probiotic in humans |
HHA |
Registered |
|
2009-07-24 |
Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study. |
CIMAB |
Registered |
|
2013-01-18 |
Safety and Pharmacology of CIGB-300 in cervical cancer (CERVIFARM-300 Study) |
CIGB |
Registered |
|
22/05/2015 |
Safety and pharmacokinetics of CIGB-552 |
CIGB |
Registered |
|
28/04/2017 |
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. |
FINLAY |
Registered outdated |
|
14/07/2020 |
Safety and immunogenicity of the CIGB 2020. |
CIGB |
Registered outdated |
